RAPAMUNE 1mg/ml oral solution PFIZER
Active substance: sirolimus
Indicated for: prevention of transplant rejection
Find medicines for human use by name or active substance.
Browse by initial
161–180 of 1,203 medicines
Active substance: sirolimus
Indicated for: prevention of transplant rejection
Active substance: sirolimus
Indicated for: prevention of transplant rejection
Active substance: sirolimus
Indicated for: prevention of transplant rejection
Active substance: landiolol
Indicated for: cardiac arrhythmias
Active substance: landiolol
Indicated for: cardiac arrhythmias
Active substance: landiolol
Indicated for: cardiac arrhythmias
Active substance: reteplase
B01AD07 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Enzymes
Indicated for: thrombolysis; myocardial infarction; ischemic stroke
Active substance: regadenosone
C01EB21 Cardiovascular system | Other cardiac preparations
Indicated for: pharmacologic stress test for myocardial perfusion
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
Active substance: rasagiline
N04BD02 Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Indicated for: Parkinson's disease
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.